Searched for
PHARMACEUTICAL FIRMS IN MEXICO
US plans additional 12.5% tariff; India says talks on Section 301 probes ongoingThe US Trade Representative has proposed an additional 12.5% duty on 54 countries, including India, over alleged failure to restrict import...
Want to jump into the 'China is back' rally? Tread carefullyInvestors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...
Auto industry flags Mexico's plan for steep tariff hike; pharma firms also worriedIndia's auto and pharma sectors are concerned as Mexico plans to more than double tariffs on countries that is doesn't have FTAs. This move...
Biocon inks supply, distribution pact with Medix for chronic weight management drug in MexicoBiocon partners with Medix to distribute Liraglutide for chronic weight management in Mexico, offering affordable obesity treatment options...
Mexico says Pfizer vaccine doses could arrive in 5-8 days"The request is being made today, and according to our contract, we could have it here in a period of something like five to eight days," D...
Zydus Cadila gets approval from Mexican authority to test COVID-19 drugLast week, Zydus had received approval from Indian authorities to start human trials for its COVID-19 vaccine contender - the second Indian...
Dr Reddy's gets EIR from USFDA for Cuernavaca plant in MexicoThe company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by ...
Mexico eases rules to hire foreign high-skilled workersMexico has the third-highest number of IT professionals in the world after India and the Philippines. About 60,000 Indians travelled to Mex...
Suven Life Sciences granted patents for neurodegenrative drugThese patents are valid until 2029. With the new patents, Suven has a total of 13 granted patents 12 from Eurasia, 12 from Japan and 17 fro...
Indian pharmaceutical companies should tap Latin American markets: BarclaysThe LatAm market, estimated at USD 60 billion with 7 per cent share of international pharma market, will be one of the engines of global gr...
Lupin completes acquisition of Mexico's Laboratories GrinMexico is one of the fastest growing pharmaceutical markets in the world valued at over $ 13.5 billion and growing at 9-10% annually.
Argentina opens $6 billion industry for Indian pharmaceutical companiesWith effect from August 8, the Latin American nation has included India on the list of countries that can supply medicines to it.
Lupin buys Mexico's Laboratorios Grin; forays into LATAM mkt"The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American (LATAM) pharmaceuticals market," Lupin Ltd ...
Suven inks licensing pact with Taro Pharma for scalp lotionSuven Life Sciences said it has given exclusive license to Taro Pharmaceutical Industries to market its Malathion Lotion.
- Eyeing for acquisitions in Brazil, Mexico, Russia: Sun Pharma
Sun Pharmaceutical Industries is eyeing for acquisitions in countries such as Brazil, Mexico and Russia, with a view to enhance presence in...
- USFDA lifts ban on Dr Reddy's Laboratories' Mexico plant
Drug firm Dr Reddy's Laboratories today said the US health regulator has lifted an import alert issued on its Mexico-based subsidiary.
- Lupin to replicate Japan model for expansion in various markets
Lupin recently enhanced its presence in Japan with the acquisition of I'rom Pharmaceuticals in November this year for an undisclosed amount.
- Glenmark Pharmaceuticals launches Immanence-IDC's anti-ageing products
Glenmark Pharmaceuticals today said it is launching anti-ageing products from the stable of Canadian firm Immanence-IDC as it forays in to ...
- Ranbaxy, Daiichi Sankyo to expand business in Mexico
The two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
- Sun Pharma plans expansion in US and large emerging markets
Sun Pharmaceuticals Industries on Friday said it is open to acquisitions in both developed and emerging markets to fuel growth.